[go: up one dir, main page]

DK0417473T3 - Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi - Google Patents

Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi

Info

Publication number
DK0417473T3
DK0417473T3 DK90115230.6T DK90115230T DK0417473T3 DK 0417473 T3 DK0417473 T3 DK 0417473T3 DK 90115230 T DK90115230 T DK 90115230T DK 0417473 T3 DK0417473 T3 DK 0417473T3
Authority
DK
Denmark
Prior art keywords
treatment
hyperplasia
cardiac
administration
well
Prior art date
Application number
DK90115230.6T
Other languages
English (en)
Inventor
Wolfgang Dr Linz
Wolfgang Dr Scholz
Hansjoerg Dr Urbach
Bernward Prof Dr Schoelkens
Gabriele Dr Wiemer
Rainer Dr Henning
Volker Dr Teetz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6386970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0417473(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0417473T3 publication Critical patent/DK0417473T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crucibles And Fluidized-Bed Furnaces (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Element Separation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK90115230.6T 1989-08-11 1990-08-08 Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi DK0417473T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926606A DE3926606A1 (de) 1989-08-11 1989-08-11 Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie

Publications (1)

Publication Number Publication Date
DK0417473T3 true DK0417473T3 (da) 1993-12-13

Family

ID=6386970

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90115230.6T DK0417473T3 (da) 1989-08-11 1990-08-08 Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi

Country Status (22)

Country Link
US (1) US5231083A (da)
EP (1) EP0417473B1 (da)
JP (1) JP3452199B2 (da)
KR (1) KR0185969B1 (da)
AT (1) ATE94409T1 (da)
AU (1) AU631914B2 (da)
CA (1) CA2023089C (da)
CS (1) CS277644B6 (da)
DD (1) DD297063A5 (da)
DE (2) DE3926606A1 (da)
DK (1) DK0417473T3 (da)
ES (1) ES2059931T3 (da)
FI (1) FI903936A7 (da)
HU (1) HU205008B (da)
IE (1) IE64604B1 (da)
IL (1) IL95327A (da)
NO (1) NO306979B1 (da)
NZ (1) NZ234836A (da)
PH (1) PH30831A (da)
PL (1) PL286442A1 (da)
PT (1) PT94957B (da)
ZA (1) ZA906327B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643911A (en) 1994-05-19 1997-07-01 Mitsubishi Chemical Corporation Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
SG68529A1 (en) * 1995-05-25 1999-11-16 Univ Singapore The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
CN1268331C (zh) * 1999-08-30 2006-08-09 萨诺费－阿文蒂斯德国有限公司 肾素－血管紧张素系统抑制剂在制备预防心血管疾病的药物中的用途
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
EP1817007A2 (en) * 2004-11-05 2007-08-15 King Pharmaceuticals Research and Development Inc. Stabilized individually coated ramipril particles, compositions and methods
EP2642998B1 (en) 2010-11-24 2020-09-16 The Trustees of Columbia University in the City of New York A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
EP3495357B1 (en) 2013-03-14 2021-05-05 The Trustees of Columbia University in the City of New York 4-phenylpiperidines, their preparation and use
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
WO2014152018A1 (en) * 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydrocyclopentapyrroles, their preparation and use
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
WO2015168286A1 (en) 2014-04-30 2015-11-05 The Trustees Of Columbia University In The City Of New York Substituted 4-phenylpiperidines, their preparaiton and use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4311705A (en) * 1980-10-06 1982-01-19 E. R. Squibb & Sons, Inc. Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines
US4337201A (en) * 1980-12-04 1982-06-29 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
US4381297A (en) * 1981-05-04 1983-04-26 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4602002A (en) * 1983-02-07 1986-07-22 Merck & Co., Inc. N-carboxymethyl substituted lysyl and α-(ε-aminoalkyl) glycyl amino acid antihypertensive agents
US4548941A (en) * 1984-07-30 1985-10-22 Merck & Co., Inc. 1,5-Methano-1H-4-benzazonine dicarboxylates, process for preparing and use as calcium blockers
US4587253A (en) * 1984-07-30 1986-05-06 Merck & Co., Inc. Bridged pyridine compounds useful as calcium channel blockers and analgesics
US4599341A (en) * 1984-10-01 1986-07-08 Merck & Co., Inc. Substituted and bridged pyridines useful as calcium channel blockers
US4656188A (en) * 1985-10-09 1987-04-07 Merck & Co., Inc. Ace inhibitors in macular degeneration
DE3705220A1 (de) * 1987-02-19 1988-09-01 Boehringer Ingelheim Kg Mittel zur behandlung von coronarerkrankungen oder organischem hirnsyndrom
ZA896851B (en) * 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors

Also Published As

Publication number Publication date
JPH0383957A (ja) 1991-04-09
DE3926606A1 (de) 1991-02-14
PL286442A1 (en) 1992-03-09
EP0417473B1 (de) 1993-09-15
NO903532D0 (no) 1990-08-10
DE59002721D1 (de) 1993-10-21
HU904966D0 (en) 1991-01-28
NO903532L (no) 1991-02-12
IL95327A0 (en) 1991-06-30
JP3452199B2 (ja) 2003-09-29
IL95327A (en) 1995-10-31
ZA906327B (en) 1991-05-29
IE902910A1 (en) 1991-02-27
CA2023089A1 (en) 1991-02-12
US5231083A (en) 1993-07-27
NO306979B1 (no) 2000-01-24
KR0185969B1 (ko) 1999-05-01
AU631914B2 (en) 1992-12-10
ES2059931T3 (es) 1994-11-16
FI903936A7 (fi) 1991-02-12
CS395890A3 (en) 1992-08-12
CS277644B6 (en) 1993-03-17
NZ234836A (en) 1997-05-26
ATE94409T1 (de) 1993-10-15
PT94957A (pt) 1991-05-22
FI903936A0 (fi) 1990-08-09
DD297063A5 (de) 1992-01-02
HU205008B (en) 1992-03-30
KR910004189A (ko) 1991-03-28
IE64604B1 (en) 1995-08-23
CA2023089C (en) 2003-01-14
AU6092090A (en) 1991-02-14
EP0417473A1 (de) 1991-03-20
HUT54504A (en) 1991-03-28
PT94957B (pt) 1997-05-28
PH30831A (en) 1997-10-17

Similar Documents

Publication Publication Date Title
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
DK0417473T3 (da) Fremgangsmåde til behandling af cardial samt vaskulær hypertrofi og hyperplasi
DK51986A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som insecticide midler
UY24244A1 (es) Derivados bicíclicos y policíclicos de isotiazolona
ES2074433T3 (es) Derivados de pirimidina, procedimiento para su produccion, y metodo herbicida y composicion.
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
DK490486D0 (da) Sammensaetning til behandling af atherosclerose, tromboser og/eller perifere karsygdomme
DK58084D0 (da) Benzazocinon- og benzazoninonderivater og salte deraf samt deres fremstilling og anvendelse
DK495683A (da) Beta-carboliner, fremgangsmaade til fremstilling af samme og farmaceutisk praeparat indeholdende samme
NO165921C (no) Fremgangsmaate for fremstilling av disubstituerte prolinderivater.
BG96171A (bg) Амидинофенилаланинови производни,метод за получаването им, приложението им и средства,които ги съдържат
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
NO952205L (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
DK282285A (da) Hidtil ukendte 8-alkylthio-2-piperazino-pyrimido(5,4-d)pyrimidiner,deres fremstilling og laegemidler indeholdende disse forbindelser
DK165247C (da) 2,3,4,5-substituerede 1,6-naphthyridinderivater, deres fremstilling samt anvendelse af disse til fremstilling af laegemidler til bekaempelse af cardiale, cerebrale og perifere karlidelser, myocardial iskaemi, cerebral infarkt, lungethrombose, stenoser, arterioscleroser og hjerte-kredsloebslidelser og laegemiddel indeholdende disse derivater
DK0736009T3 (da) N-oxider af 4-arylpiperaziner og 4-arylpiperidiner som antipsykotiske medikamenter
ES2103104T3 (es) Nuevos compuestos di- y poliaminicos utiles en la preparacion de poliuretanos.
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
DK440987A (da) Thyroninderivater, deres fremstilling og anvendelse
FI931838A0 (fi) Oxosulfonylkarbamater
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
ES2147316T3 (es) 1-cicloalqueniltetrazolinonas.
DK572189A (da) Substituerede adeninderivater og farmaceutisk praeparat indeholdende dem
CO4700283A1 (es) Compuestos novedosos